Effective Date: January 22, 2026
Last Updated: January 22, 2026
This page provides important safety information about compounded semaglutide offered through Vea Health, Inc. (“Vea Health,” “we,” “us,” or “our”). This information is intended for educational purposes only and does not replace consultation with a licensed healthcare provider.
What Is Compounded Semaglutide
Semaglutide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. It works by affecting appetite regulation and blood sugar control. Compounded semaglutide is prepared by licensed compounding pharmacies when commercially manufactured versions are not suitable or available for a patient, as determined by a healthcare provider.
Compounded medications are not FDA-approved, but they are permitted under federal law when prescribed by a licensed provider and prepared by a licensed pharmacy in accordance with applicable regulations.
Medical Review Required
Compounded semaglutide is prescribed only after a licensed healthcare provider reviews your medical history and determines that treatment is medically appropriate. Use of Vea Health’s services does not guarantee that semaglutide will be prescribed.
Who Should Not Use Compounded Semaglutide
Compounded semaglutide may not be appropriate for individuals who:
Have a personal or family history of medullary thyroid carcinoma
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Have a known allergy or sensitivity to semaglutide or related compounds
Are pregnant or breastfeeding, unless specifically approved by a provider
Your provider will evaluate additional risk factors during the clinical review process.
Potential Side Effects
As with any medication, semaglutide may cause side effects. Commonly reported side effects may include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal discomfort
Decreased appetite
Side effects are often dose-dependent and may occur more frequently when starting treatment or increasing dosage.
Serious Risks and Warnings
More serious adverse effects may occur, including but not limited to:
Severe gastrointestinal symptoms
Pancreatitis
Gallbladder issues
Changes in blood sugar levels
Seek immediate medical attention if you experience severe or persistent symptoms.
Dosing and Administration
Dosing is individualized and determined by a licensed healthcare provider. You should use compounded semaglutide only as prescribed and follow all instructions provided by your provider and pharmacy.
Do not adjust dosage or frequency without medical guidance.
Medication Quality and Compounding
Compounded semaglutide provided through Vea Health is prepared by licensed U.S. compounding pharmacies. These pharmacies are responsible for sourcing ingredients and preparing medications in compliance with applicable pharmacy standards and regulations.
No Guarantee of Results
Individual responses to semaglutide vary. Vea Health does not guarantee weight loss, blood sugar control, or any specific outcome. Results depend on multiple factors including medical history, adherence, and lifestyle considerations.
Not for Emergency Use
Compounded semaglutide is not intended for emergency medical situations. If you are experiencing a medical emergency, call 911 or seek immediate in-person care.
Questions or Concerns
If you experience side effects, have concerns about your medication, or believe treatment may not be appropriate, contact your healthcare provider promptly.
Contact Information
For general questions related to compounded semaglutide safety, contact:
Vea Health, Inc.
8 The Green, STE A
Dover, DE 19901
Email: team@veahealth.co